Osaic Holdings
BIOL

Osaic Holdings’s Biolase, Inc. BIOL Stock Holding History

Osaic Holdings’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50
Closed -$56 – 7462
2023
Q4 		$56 Hold
50
– – ﹤0.01% 7157
2023
Q3 		$93 Sell
50
-2
-4% -$11 ﹤0.01% 7235
2023
Q2 		$375 Buy
52
+49
+1,633% +$820 ﹤0.01% 7106
2023
Q1 		$66 Hold
3
– – ﹤0.01% 7359
2022
Q4 		$10 Buy
+3
New +$432 ﹤0.01% 7133
2022
Q3 		– Hold
0
– – – 7583
2022
Q2 		– Hold
0
– – – 7671
2022
Q1 		– Sell
-2
Closed -$1.84K – 7599
2021
Q4 		$2K Hold
2
– – ﹤0.01% 7080
2021
Q3 		$3K Buy
+2
New +$3.27K ﹤0.01% 6790
2021
Q2 		– Sell
-2
Closed -$3.71K – 7174
2021
Q1 		$3K Buy
+2
New +$4.92K ﹤0.01% 6423
2020
Q4 		– Sell
-1
Closed -$763 – 6634
2020
Q3 		$1K Buy
+1
New +$938 ﹤0.01% 6104
2020
Q2 		– Hold
0
– – – 6393
2020
Q1 		– Hold
0
– – – 6229

Other funds holding BIOL

VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
KWA
Kellett Wealth Advisors Cincinnati, Ohio $215M AUM 22.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Osaic Holdings's BIOL Position: Q1 2024 in Review

Osaic Holdings sold out of Biolase, Inc. (BIOL) in Q1 2024, closing a stake of 50 shares — an estimated $56 sold.

Osaic Holdings first reported a position in BIOL in Q3 2020 and held it in 9 quarters. The position peaked at $3K in Q3 2021. 18 funds tracked by Wall St. Rank hold BIOL as of Q1 2024.

  • Osaic Holdings reported no remaining Biolase, Inc. position as of Q1 2024 after selling out during the quarter.
  • Osaic Holdings sold 50 Biolase, Inc. shares in Q1 2024, an estimated $56.
  • Osaic Holdings first reported a position in Biolase, Inc. in Q3 2020 and held it in 9 quarters.
  • Osaic Holdings's Biolase, Inc. position peaked at $3K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Biolase, Inc. as of Q1 2024.

Based on Osaic Holdings's 13F filing for Q1 2024, filed 10 May 2024.